Cargando…
Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy
To evaluate the therapeutic benefit of lymphadenectomy and adjuvant therapy, in particular chemotherapy, we retrospectively analysed survival rates and patterns of recurrence of endometrioid adenocarcinoma in 106 patients who underwent surgery including retroperitoneal lymphadenectomy. Adjuvant chem...
Autores principales: | Otsuka, I, Kubota, T, Aso, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376140/ https://www.ncbi.nlm.nih.gov/pubmed/12177772 http://dx.doi.org/10.1038/sj.bjc.6600468 |
Ejemplares similares
-
Therapeutic Benefit of Systematic Lymphadenectomy in Node-Negative Uterine-Confined Endometrioid Endometrial Carcinoma: Omission of Adjuvant Therapy
por: Otsuka, Isao
Publicado: (2022) -
Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
por: Otsuka, Isao, et al.
Publicado: (2022) -
Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma
por: Amant, F, et al.
Publicado: (2007) -
High-grade uterine corpus-confined endometrial cancer with lymphadenectomy: does adjuvant therapy improve survival?
por: Kılıç, Çiğdem, et al.
Publicado: (2019) -
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial
por: Maggi, R, et al.
Publicado: (2006)